UNSPSC 51182073: Testosterone hexahydrobenzoate

This classification denotes an androgen with the molecular formula C26H38O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T4QOX8847Z, chemically known as androst-4-en-3-one, 17-((cyclohexylcarbonyl)oxy)-, (17.beta.)-, but more generally known as testosterone hexahydrobenzoate, which bears US NIH Compound Identifier 85694. European Medicines Agency schedules testosterone hexahydrobenzoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10937MIG.

Most nations, for tariff purposes, schedule testosterone hexahydrobenzoate under HS 29372900. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C4CCCCC4)CCC5=CC(=O)CC[C@]35C.

UNSPSC 51182073 Testosterone hexahydrobenzoate is a Commodity code covering a synthetic steroid compound used in medical and pharmaceutical contexts. State and local procurement activity under this code reflects purchases of this specific pharmaceutical ingredient or formulation by public health departments, correctional facilities, state hospitals, and other public-sector healthcare providers for clinical or therapeutic use. The code sits at the narrowest tier of the UNSPSC hierarchy, targeting a single product line rather than a broader family of related goods.

No recent state and local contract opportunities are present in the source material for this code. The absence of posted solicitations may reflect the specialized nature of the commodity, the limited number of public agencies with clinical demand for this particular steroid formulation, or the use of standing pharmaceutical contracts or cooperative purchasing vehicles through which such acquisitions are made rather than individual RFPs or IFBs.